Full-Life Technologies
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A fully integrated radiopharmaceutical company developing targeted cancer therapies and diagnostics.
Oncology
Technology Platform
Integrated platform for targeted radiopharmaceutical development, encompassing novel ligand discovery, radiochemistry, and radioisotope production.
Opportunities
Capitalizing on the global resurgence and high clinical demand for targeted radiopharmaceuticals in oncology.
Risk Factors
Faces significant technical and regulatory hurdles in manufacturing and distributing radioactive drugs.
Competitive Landscape
Competes with global radiopharmaceutical leaders like Novartis and Bayer, but its integrated isotope-to-therapy model is a key differentiator in China.